BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 29341071)

  • 1. Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
    Bergman H; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000204. PubMed ID: 29341071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic medication for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2000; (2):CD000204. PubMed ID: 10796321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Rathbone J; Ogawa Y; Shinohara K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000208. PubMed ID: 29552749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for antipsychotic-induced tardive dyskinesia.
    Essali A; Soares-Weiser K; Bergman H; Adams CE
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000206. PubMed ID: 29578611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.
    Bergman H; Rathbone J; Agarwal V; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD000459. PubMed ID: 29409162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E for antipsychotic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000209. PubMed ID: 29341067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Bergman H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000203. PubMed ID: 29663328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepines for antipsychotic-induced tardive dyskinesia.
    Bergman H; Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000205. PubMed ID: 29352477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic medication for antipsychotic-induced tardive dyskinesia.
    Tammenmaa-Aho I; Asher R; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD000207. PubMed ID: 29553158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
    Soares-Weiser K; Rathbone J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2001; (4):CD000209. PubMed ID: 11687073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser K; Maayan N; McGrath J
    Cochrane Database Syst Rev; 2011 Feb; (2):CD000209. PubMed ID: 21328246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ; Deeks JJ
    Cochrane Database Syst Rev; 2001; (2):CD000203. PubMed ID: 11405955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Soares K; Rathbone J; Deeks J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000203. PubMed ID: 15494993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
    Alabed S; Latifeh Y; Mohammad HA; Rifai A
    Cochrane Database Syst Rev; 2011 Apr; (4):CD000203. PubMed ID: 21491376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone (depot) for schizophrenia.
    Sampson S; Hosalli P; Furtado VA; Davis JM
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia.
    Soares-Weiser KV; Joy C
    Cochrane Database Syst Rev; 2003; (2):CD000208. PubMed ID: 12804390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.